Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Allergen immunotherapy (Patch tests / prick tests - Allergen immunotherapy)

Records returned : 11 (on 29 May 2025 at 11:16:49). Return to search results for ' Allergen immunotherapy '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Patch tests / prick tests

Drug:

Patch tests / prick tests

Indication :

Allergen immunotherapy

Status :

Red

Restrictions / Comments:

Important

RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Allergovit (pollen)

Drug:

Allergovit (pollen)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Allergovit - RSFT Immunology only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Allergovit (pollen)

Drug:

Allergovit (pollen)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Sub-lingual drops

Restrictions / Comments:

Important

Oralvac Compact drops - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Allergovit (pollen)

Drug:

Allergovit (pollen)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Pollinex quattro - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Allergovit (pollen)

Drug:

Allergovit (pollen)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Sublingual tablets

Restrictions / Comments:

Important

Lais tablets (grass pollen) - RSFT immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Alutard (wasp and bee)

Drug:

Alutard (wasp and bee)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Alutard - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Alutard (wasp and bee)

Drug:

Alutard (wasp and bee)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Venomil - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. House dust mites allergen extract

Drug:

House dust mites allergen extract

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Oral lyophilisates

Restrictions / Comments:

Important

Acarizax - RSFT Immunology and specialist paediatricians only. Approved in over 18s only. Licensed in children over 12 years.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. House dust mites allergen extract

Drug:

House dust mites allergen extract

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Acaroid - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. House dust mites allergen extract

Drug:

House dust mites allergen extract

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Sublingual tablets

Restrictions / Comments:

Important

Lais sublingual tablets - RSFT Immunology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Itulazax (birch pollen)

Drug:

Itulazax (birch pollen)

Indication :

Allergen immunotherapy

Status :

Red

Formulations :

Oral lyophilisates

Restrictions / Comments:

Important

Ituluzax (birch pollen) - RSFT Immunology only. Approved for over 18s only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC